Transce3nd’s Oracle ORCL Stock Holding History

Transce3nd’s Portfolio ORCL Stock Details ORCL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-1,129	Closed	-$247K	–	828
2025 Q2	$247K	Sell	1,129 -118	-9%	-$19.1K	0.1%	123
2025 Q1	$174K	Sell	1,247 -387	-24%	-$63K	0.08%	156
2024 Q4	$272K	Buy	+1,634	New	+$290K	0.09%	140

Other funds holding ORCL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Transce3nd's ORCL Position: Q3 2025 in Review

Transce3nd sold out of Oracle (ORCL) in Q3 2025, closing a stake of 1,129 shares — an estimated $247K sold.

Transce3nd first reported a position in ORCL in Q4 2024 and held it in 3 quarters. The position peaked at $272K in Q4 2024. 3,820 funds tracked by Wall St. Rank hold ORCL as of Q3 2025.

Transce3nd reported no remaining Oracle position as of Q3 2025 after selling out during the quarter.
Transce3nd sold 1,129 Oracle shares in Q3 2025, an estimated $247K.
Transce3nd first reported a position in Oracle in Q4 2024 and held it in 3 quarters.
Transce3nd's Oracle position peaked at $272K in Q4 2024.
3,820 funds tracked by Wall St. Rank held Oracle as of Q3 2025.

Based on Transce3nd's 13F filing for Q3 2025, filed 12 Nov 2025.